AdvanDx to Offer Inverness' Test for MRSA Protein Detection | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AdvanDx today said that it will offer Inverness Medical Innovations' BinaxNow PBP2a test in the US.

The test, which is an antibody-based rapid immunochromatographic membrane assay, received 510(k) clearance from the US Food and Drug Administration last month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.